State Senator from Shreveport-Bossier seeks to curb over-the-top, dishonest ads
Cottrell v. Alcon Laboratories
(3rd Cir., filed September 28, 2016): Arguing that the plaintiffs’ speculative claim that they might have paid less for a medication if defendants had packaged it more efficiently does not describe a cognizable injury in fact, and therefore, they lack standing. Accepting plaintiffs’ theory would invite abusive class-action litigation.
On October 18, 2017, the Court ruled against ATRA’s position and reversed the dismissal of the class action.
Bill on seat belt admissibility heads to Governor
SCOTUS Determining Whether to Hear Appeal by Defendant
Writing for The Hill, ATRA President Tiger Joyce discusses the Biden administration’s plans to allow a settlement slush fund and issues the practice has caused at the state level.
ATRA President Tiger Joyce writes about issues with a landmark talc case in Missouri and how the U.S. Supreme Court can step in.